growing number of end stage renal disease patients and increasing prevalence of diabetes and hypertension are driving the growth of the dialysis market. In addition, factors such as low preference of patients for kidney transplantation, technological advancements, increase in private investment and venture funding to support the development of new products, and substantial government healthcare expenditure on the treatment of end-stage renal disease are further stimulating the growth of the dialysis products and services market. However, factors such as low awareness about kidney diseases and their treatment modalities (primarily in developing countries), reduction in Medicare reimbursements to dialysis centers, product recalls, and reuse of hemodialysis consumables (such as dialyzers and bloodlines) are restraining the growth of the dialysis market.
In 2013, North America holds the largest share in the global dialysis market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the dialysis market in the Asia-Pacific region.
The major players in the dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.).
Major Point of table of content:
11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
Page: 1 2 3 Related medicine news :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Hemodialysis Treatment for Kidney Failure Information Guide Released by Online Health Resource Agingfit.com2
. Fish Oil Doesnt Cut Failure Rate of Hemodialysis Grafts3
. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Release of Emails from Johnson & Johnson’s Janssen Subsidiary in Federal Risperdal Settlement4
. Heritage Woods of Gurnee Affordable Assisted Living to Host a Holiday Bake Sale & Craft Bazaar5
. John Langdoc of Baron & Budd Inducted into Texas Lawyer Hall of Fame6
. Diet Doc Hormone Diets & Weight Loss Plans Introduce New Paleo Recipes and Low Calorie Diet Foods, Enhanced by Weight Loss Supplements, for Fast Results7
. Diet Doc Hormone Diets & Weight Loss Plans Now Offer Extreme Weight Loss Diet Plans for Patients Who Need Extra Help With Losing Weight to Fly8
. Essential Wholesale & Labs Offers Natural Solution for Head Lice9
. Bioinformatics Market (Molecular Medicine, Agriculture, Research & Forensic) worth $7.5 Billion by 2017 - New Report by MarketsandMarkets10
. Baron & Budd Supports Encouraging New Development in Mesothelioma Treatment11
. Diet Doc Hormone Diets & Weight Loss Plans Now Helps Patients Reach a Healthy Weight With Low Fat Diets, Now Found to Reduce the Risk of Early Death